- Home
- DTIL vs WLGS Comparison
DTIL vs WLGS Comparison
Compare DTIL & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- WLGS
- Stock Information
- Founded
- DTIL 2006
- WLGS 1981
- Country
- DTIL United States
- WLGS Hong Kong
- Employees
- DTIL N/A
- WLGS N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- WLGS Engineering & Construction
- Sector
- DTIL Health Care
- WLGS Consumer Discretionary
- Exchange
- DTIL Nasdaq
- WLGS Nasdaq
- Market Cap
- DTIL 44.1M
- WLGS 41.7M
- IPO Year
- DTIL 2019
- WLGS 2023
- Fundamental
- Price
- DTIL $4.51
- WLGS $2.21
- Analyst Decision
- DTIL Strong Buy
- WLGS
- Analyst Count
- DTIL 2
- WLGS 0
- Target Price
- DTIL $39.50
- WLGS N/A
- AVG Volume (30 Days)
- DTIL 104.8K
- WLGS 127.2K
- Earning Date
- DTIL 11-04-2024
- WLGS 12-24-2024
- Dividend Yield
- DTIL N/A
- WLGS N/A
- EPS Growth
- DTIL N/A
- WLGS N/A
- EPS
- DTIL 1.45
- WLGS N/A
- Revenue
- DTIL $75,096,000.00
- WLGS $6,825,879.00
- Revenue This Year
- DTIL $50.33
- WLGS N/A
- Revenue Next Year
- DTIL N/A
- WLGS N/A
- P/E Ratio
- DTIL $3.21
- WLGS N/A
- Revenue Growth
- DTIL 43.62
- WLGS 63.69
- 52 Week Low
- DTIL $4.56
- WLGS $0.44
- 52 Week High
- DTIL $19.43
- WLGS $5.57
- Technical
- Relative Strength Index (RSI)
- DTIL 24.26
- WLGS 38.98
- Support Level
- DTIL $5.12
- WLGS $2.31
- Resistance Level
- DTIL $6.18
- WLGS $3.19
- Average True Range (ATR)
- DTIL 0.46
- WLGS 0.65
- MACD
- DTIL -0.13
- WLGS -0.23
- Stochastic Oscillator
- DTIL 5.21
- WLGS 2.96
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.